Search Results

Azelastine and olopatadine in the treatment of allergic rhinitis

Author: Kaliner, Michael A.

Source: Annals of Allergy, Asthma and Immunology, Volume 103, Number 5, November 2009 , pp. 373-380(8)

Publisher: American College of Allergy, Asthma, & Immunology

Antihistamines treatment for allergic rhinitis: Different routes, different mechanisms?

Author: Hernandez-Trujillo, Vivian

Source: Allergy and Asthma Proceedings, Volume 30, Number 6, November/December 2009 , pp. 584-588(5)

Publisher: OceanSide Publications, Inc

Antihistamine treatment for allergic rhinitis: Different routes, different outcomes?

Authors: Chipps, Bradley E.; Harder, Julia M.

Source: Allergy and Asthma Proceedings, Volume 30, Number 6, November/December 2009 , pp. 589-594(6)

Publisher: OceanSide Publications, Inc

Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis

Authors: Berger, William E.; Ratner, Paul H.; Casale, Thomas B.; Meltzer, Eli O.; Wall, G. Michael

Source: Allergy and Asthma Proceedings, Volume 30, Number 6, November/December 2009 , pp. 612-623(12)

Publisher: OceanSide Publications, Inc

Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells

Authors: SUGITA, Kazunari; KOBAYASHI, Miwa; MORI, Tomoko; KABASHIMA, Kenji; NAKAMURA, Motonobu; TOKURA, Yoshiki

Source: Journal of Dermatology, Volume 36, Number 12, December 2009 , pp. 654-657(4)

Publisher: Blackwell Publishing

Intranasal antihistamines for allergic rhinitis: Mechanism of action

Author: Lieberman, Philip

Source: Allergy and Asthma Proceedings, Volume 30, Number 4, July/August 2009 , pp. 345-348(4)

Publisher: OceanSide Publications, Inc

Intranasal antihistamines for allergic rhinitis: Examining the clinical impact

Authors: Cassell, Heather R.; Katial, Rohit K.

Source: Allergy and Asthma Proceedings, Volume 30, Number 4, July/August 2009 , pp. 349-357(9)

Publisher: OceanSide Publications, Inc

Pharmacokinetics of Orally Administered Single- and Multiple-Dose Olopatadine in Healthy Chinese Subjects: An Open-Label Study

Authors: Chu, Nan-Nan; Chen, Wei-Li; Xu, Hong-Rong; Li, Xue-Ning

Source: Clinical Drug Investigation, Volume 29, Number 7, 5 June 2009 , pp. 451-457(7)

Publisher: Adis International

Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 μg in the treatment of seasonal allergic rhinitis

Authors: Kaliner, Michael A.; Storms, William; Tilles, Stephen; Spector, Sheldon; Tan, Ricardo; LaForce, Craig; Lanier, Bobby Q.; Chipps, Bradley

Source: Allergy and Asthma Proceedings, Volume 30, Number 3, May-June 2009 , pp. 255-262(8)

Publisher: OceanSide Publications, Inc

Histamine H1 receptor antagonists: Urticaria, abdominal pain and vomiting: case report

Source: Reactions, Volume 1, Number 1253, 2009-05-23 , pp. 20-21(2)

Publisher: Adis International

Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride

Authors: HOSOKAWA, Chisato; TAKEUCHI, Satoshi; FURUE, Masutaka

Source: Journal of Dermatology, Volume 36, Number 4, April 2009 , pp. 185-190(6)

Publisher: Blackwell Publishing

Use of olopatadine ophthalmic solution and reactivity of histamine skin testing

Authors: Jones, Jeremy D.; Temino, Viviana M.; Dworski, Ryszard; Anderson, Cindy K.; Fahrenholz, John M.; An, Angel Qi

Source: Allergy and Asthma Proceedings, Volume 29, Number 6, November-December 2008 , pp. 636-639(4)

Publisher: OceanSide Publications, Inc

A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis

Authors: Rosenwasser, Lanny J.; Mahr, Todd; Abelson, Mark B.; Gomes, Paul J.; Kennedy, Kathryn

Source: Allergy and Asthma Proceedings, Volume 29, Number 6, November-December 2008 , pp. 644-653(10)

Publisher: OceanSide Publications, Inc

Comparative study of sensory attributes of two antihistamine nasal sprays: Olopatadine 0.6% and azelastine 0.1%

Authors: Meltzer, Eli O.; Garadi, Rekha; LaForce, Craig; Chadwick, Stephen J.; Berger, William E.; Gross, Gary; Edwards, Michael R.; Crenshaw, Krista; Wall, G. Michael

Source: Allergy and Asthma Proceedings, Volume 29, Number 6, November-December 2008 , pp. 659-668(10)

Publisher: OceanSide Publications, Inc

Effects of olopatadine in limited scleroderma with peripheral eosinophils

Authors: Kikuchi, Motoo; Inagaki, Toshiaki; Hanaki, Hidekazu; Harada, Shinsuke; Ueda, Ryuzo

Source: Geriatrics and Gerontology International, Volume 8, Number 3, September 2008 , pp. 204-208(5)

Publisher: Blackwell Publishing

Nonseasonal Allergic Conjunctivitis in the Tropics: Experience in a Tertiary Care Institution

Authors: Choi, Harold; Lee, Sao Bing

Source: Ocular Immunology and Inflammation, Volume 16, Number 4, August 2008 , pp. 141-145(5)

Publisher: Informa Healthcare

Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis

Authors: Takahashi, Hitoshi; Zhang, Yan; Morita, Eishin

Source: Archives of Dermatological Research, Volume 300, Number 6, July 2008 , pp. 291-295(5)

Publisher: Springer

The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation

Authors: Pipkorn, Patrik; Costantini, Candy; Reynolds, Curt; Wall, Michael; Drake, Margaret; Sanico, Alvin; Proud, David; Togias, Alkis

Source: Annals of Allergy, Asthma and Immunology, Volume 101, Number 1, July 2008 , pp. 82-89(8)

Publisher: American College of Allergy, Asthma, & Immunology

Enhancement of basophil apoptosis by olopatadine and theophylline

Authors: Kawakami, Ayako; Suzukawa, Maho; Koketsu, Rikiya; Komiya, Akiko; Ohta, Ken; Yamamoto, Kazuhiko; Yamaguchi, Masao

Source: Allergy and Asthma Proceedings, Volume 29, Number 3, May-June 2008 , pp. 322-328(7)

Publisher: OceanSide Publications, Inc

Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing

Authors: Abelson, Mark B; Gomes, Paul J

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 4, Number 4, April 2008 , pp. 453-461(9)

Publisher: Informa Healthcare